Strengthening Skills Program for Autism Spectrum Disorders

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Autism Spectrum Disorders+3 More
Strengthening Skills Program - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is examining whether a combination of therapies can help improve the lives of adults with ASD.

Eligible Conditions
  • Autism Spectrum Disorders
  • Autism Spectrum Disorder

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Autism Spectrum Disorders

Study Objectives

3 Primary · 1 Secondary · Reporting Duration: Post-Intervention (16 weeks); 3-month follow-up; 6-month follow-up

Post-Intervention (16 weeks)
Mean Change from Baseline in Prospective Memory on the Royal Prince Alfred Prospective Memory Test
Week 16
Mean Change from Baseline in Adaptive Functioning on the Adaptive Behavior Assessment System, Third Edition (ABAS-3)
Mean Change from Baseline in Self-reported Quality of Life on the WHOQOL-BREF
Mean Change from Baseline in Self-reported Quality of Life on the World Health Organization's Brief Quality of Life assessment (WHOQOL-BREF)

Trial Safety

Safety Progress

1 of 3

Other trials for Autism Spectrum Disorders

Trial Design

3 Treatment Groups

PEERS Social Skills Program
1 of 3
Delayed Treatment Control Group
1 of 3
Strengthening Skills Program
1 of 3
Active Control
Experimental Treatment

42 Total Participants · 3 Treatment Groups

Primary Treatment: Strengthening Skills Program · No Placebo Group · N/A

Strengthening Skills ProgramExperimental Group · 2 Interventions: Strengthening Skills Program, PEERS Social Skills Program · Intervention Types: Behavioral, Behavioral
PEERS Social Skills Program
Behavioral
ActiveComparator Group · 1 Intervention: PEERS Social Skills Program · Intervention Types: Behavioral
Delayed Treatment Control GroupNoIntervention Group · 1 Intervention: Delayed Treatment Control Group · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: post-intervention (16 weeks); 3-month follow-up; 6-month follow-up

Who is running the clinical trial?

Mayo ClinicOTHER
2,891 Previous Clinical Trials
3,698,365 Total Patients Enrolled
Arizona State UniversityOTHER
238 Previous Clinical Trials
89,084 Total Patients Enrolled
Southwest Autism Research & Resource CenterLead Sponsor
4 Previous Clinical Trials
344 Total Patients Enrolled
Brittany B Braden, Ph.D.Principal InvestigatorArizona State University
Nicole L Matthews, Ph.D.Principal InvestigatorSouthwest Autism Research & Resource Center

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 31st, 2021

Last Reviewed: October 16th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

Who else is applying?

What state do they live in?
Pennsylvania66.7%
New York33.3%
How old are they?
18 - 65100.0%
What portion of applicants met pre-screening criteria?
Did not meet criteria100.0%